Published date: 3 August 2022
Awarded contract - This means that the contract has been awarded to a supplier.
Contract summary
Industry
Blood products - 33141510
Location of contract
LE1 5WW
Value of contract
£0 to £97,500
Procurement reference
CF-1009100D0O000000rwimUAA1
Published date
3 August 2022
Closing date
1 June 2022
Closing time
12pm
Contract start date
1 July 2022
Contract end date
30 June 2024
Contract type
Supply contract
Procedure type
Call-off from a framework agreement
A mini-competition or direct purchase from a pre-established framework agreement.
Contract is suitable for SMEs?
No
Contract is suitable for VCSEs?
No
Description
Octaplas, blood product required for the treatment of TTP patients.
CMU National Framework Agreement for the supply of products for the treatment of Bleeding Disorders including Haemophilia B
Offer reference number: CM/PHS/19/5576
Award information
Awarded date
2 August 2022
Contract start date
1 July 2022
Contract end date
30 June 2024
Total value of contract
£97,500
This contract was awarded to 1 supplier.
Octapharma Limited
Address
The Zenith Building, 26 Spring Gardens, Manchester M2 1AB
Reference
None
About the buyer
Contact name
Puvandeep Badyal
Address
Level 3 Balmoral Building, Infirmary Square
Leicester
LE1 5WW
GB
Telephone
07960558252
Share this notice
Closing: 1 June 2022, 12pm